Format

Send to

Choose Destination
Lab Chip. 2010 Jan 7;10(1):27-9. doi: 10.1039/b917959c. Epub 2009 Nov 16.

Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody.

Author information

1
Sibley School of Mechanical & Aerospace Engineering, College of Engineering, Cornell University, Ithaca, NY 14853, USA.

Abstract

Geometrically enhanced differential immunocapture (GEDI) and an antibody for prostate-specific membrane antigen (PSMA) are used for high-efficiency and high-purity capture of prostate circulating tumor cells from peripheral whole blood samples of castrate-resistant prostate cancer patients.

PMID:
20024046
PMCID:
PMC3031459
DOI:
10.1039/b917959c
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Royal Society of Chemistry Icon for PubMed Central
Loading ...
Support Center